• Je něco špatně v tomto záznamu ?

Analysis of transcriptomics data from COVID-19 patients: a pilot research

D. Hadzega, K. Babisova, M. Hyblova, N. Janostiakova, P. Sabaka, P. Janega, G. Minarik

. 2024 ; 69 (1) : 155-164. [pub] 20240119

Jazyk angličtina Země Česko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24003878

Grantová podpora
ITMS: 313011AVH7 OP Integrated Infrastructure for the project: Serious diseases of civilization and Covid19

During SARS-CoV-2 infection, the virus transforms the infected host cell into factories that produce new viral particles. As infection progresses, the infected cells undergo numerous changes in various pathways. One of these changes is the occurrence of a cytokine storm, which leads to severe symptoms. In this study, we examined the transcriptomic changes caused by COVID-19 by analyzing RNA-seq data obtained from COVID-19-positive patients as well as COVID-19-negative donors. RNA-seq data were collected for the purpose of identification of potential biomarkers associated with a different course of the disease. We analyzed the first datasets, consisting of 96 samples to validate our methods. The objective of this publication is to report the pilot results. To explore potential biomarkers related to disease severity, we conducted a differential expression analysis of human transcriptome, focusing on COVID-19 positivity and symptom severity. Given the large number of potential biomarkers we identified, we further performed pathway enrichment analysis with terms from Kyoto Encyclopedia of Genes and Genomics (KEGG) to obtain a more profound understanding of altered pathways. Our results indicate that pathways related to immune processes, response to infection, and multiple signaling pathways were affected. These findings align with several previous studies that also reported the influence of SARS-CoV-2 infection on these pathways.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24003878
003      
CZ-PrNML
005      
20240305161717.0
007      
ta
008      
240305s2024 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s12223-024-01130-x $2 doi
035    __
$a (PubMed)38240884
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Hadzega, Dominik $u Medirex Group Academy, Nitra, Slovakia $1 https://orcid.org/0009000710838244
245    10
$a Analysis of transcriptomics data from COVID-19 patients: a pilot research / $c D. Hadzega, K. Babisova, M. Hyblova, N. Janostiakova, P. Sabaka, P. Janega, G. Minarik
520    9_
$a During SARS-CoV-2 infection, the virus transforms the infected host cell into factories that produce new viral particles. As infection progresses, the infected cells undergo numerous changes in various pathways. One of these changes is the occurrence of a cytokine storm, which leads to severe symptoms. In this study, we examined the transcriptomic changes caused by COVID-19 by analyzing RNA-seq data obtained from COVID-19-positive patients as well as COVID-19-negative donors. RNA-seq data were collected for the purpose of identification of potential biomarkers associated with a different course of the disease. We analyzed the first datasets, consisting of 96 samples to validate our methods. The objective of this publication is to report the pilot results. To explore potential biomarkers related to disease severity, we conducted a differential expression analysis of human transcriptome, focusing on COVID-19 positivity and symptom severity. Given the large number of potential biomarkers we identified, we further performed pathway enrichment analysis with terms from Kyoto Encyclopedia of Genes and Genomics (KEGG) to obtain a more profound understanding of altered pathways. Our results indicate that pathways related to immune processes, response to infection, and multiple signaling pathways were affected. These findings align with several previous studies that also reported the influence of SARS-CoV-2 infection on these pathways.
650    _2
$a lidé $7 D006801
650    12
$a COVID-19 $x genetika $7 D000086382
650    _2
$a SARS-CoV-2 $x genetika $7 D000086402
650    _2
$a stanovení celkové genové exprese $7 D020869
650    _2
$a genomika $7 D023281
650    _2
$a biologické markery $7 D015415
655    _2
$a časopisecké články $7 D016428
700    1_
$a Babisova, Klaudia $u Medirex Group Academy, Nitra, Slovakia
700    1_
$a Hyblova, Michaela $u Medirex Group Academy, Nitra, Slovakia
700    1_
$a Janostiakova, Nikola $u Comenius University in Bratislava, Medical Faculty, Institute of Medical Biology, Genetics and Clinical Genetics, Špitálska 24, Bratislava, Slovakia
700    1_
$a Sabaka, Peter $u Department of Infectology and Geographical Medicine, Faculty of Medicine, Comenius University in Brati-Slava, Bratislava, Slovakia
700    1_
$a Janega, Pavol $u Medirex Group Academy, Nitra, Slovakia
700    1_
$a Minarik, Gabriel $u Medirex Group Academy, Nitra, Slovakia. gabriel.minarik@medirex.sk
773    0_
$w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 69, č. 1 (2024), s. 155-164
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38240884 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240305 $b ABA008
991    __
$a 20240305161714 $b ABA008
999    __
$a ok $b bmc $g 2059327 $s 1213630
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 69 $c 1 $d 155-164 $e 20240119 $i 1874-9356 $m Folia microbiologica $n Folia microbiol. (Prague) $x MED00011005
GRA    __
$a ITMS: 313011AVH7 $p OP Integrated Infrastructure for the project: Serious diseases of civilization and Covid19
LZP    __
$a Pubmed-20240305

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...